An adenovirus traffic update: From receptor engagement to the nuclear pore

Future Microbiology

Volumn 6, Issue 2, 2011, Pages 179-192

  Henaff, Daniel ^a,b   Salinas, Sara ^a,b   Kremer, Eric J ^a,b  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

adenovirus; CAR; CD46; endosomolysis; MTOC; receptor; trafficking

Indexed keywords

MEMBRANE COFACTOR PROTEIN; VIRUS RECEPTOR;

ADENOVIRUS; CONFORMATIONAL TRANSITION; ENDOSOME; GENE TRANSLOCATION; HUMAN; MEMBRANE BINDING; MICROENVIRONMENT; NONHUMAN; NUCLEAR PORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS ENTRY; VIRUS MORPHOLOGY;

ADENOVIRIDAE; ENDOSOMES; HUMANS; NUCLEAR PORE; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

ADENOVIRIDAE;

EID: 79952433168     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.162     Document Type: Review

References (153)

1. Davison AJ, Benko M, Harrach B: Genetic content and evolution of adenoviruses. J. Gen. Virol. 84(Pt 11), 2895-2908 (2003). (Pubitemid 37336773)
2. Janoska M, Vidovszky M, Molnar V, Liptovszky M, Harrach B, Benko M: Novel adenoviruses and herpesviruses detected in bats. Vet. J. DOI:10.1016/j.tvjl. 2010.06.020 (2010) (Epub ahead of print).
3. Colloca S: Novel adenovirus vectors from chimpanzees: Technology platform for genetic vaccine applications. Presented at: 9th International Adenovirus Meeting. Dobogóko, Hungary 26-30 April 2009.
4. Kaneko H, Suzutani T, Aoki K et al.: Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br. J. Ophthalmol. 95(1), 32-36 (2011).
5. Maa AG, Salam MA, Alim MA, Haque AE, Islam QT: Seroconversion after recombinant hepatitis B vaccination. J. Med. 11(2), 143-150 (2010).
6. Hierholzer JC: Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5(3), 262-274 (1992).
7. Walls T, Shankar AG, Shingadia D: Adenovirus: An increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect. Dis. 3(2), 79-86 (2003). (Pubitemid 36164203)
8. Omar H, Yun Z, Lewensohn-Fuchs I et al.: Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia. Transpl. Infect. Dis. DOI: 10.1111/j.1399-3062.2010.00528.x (2010) (Epub ahead of print).
9. Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC: Respiratory diseases among U.S. Military personnel: Countering emerging threats. Emerg. Infect. Dis. 5(3), 379-385 (1999).
10. Russell KL, Broderick MP, Franklin SE et al.: Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J. Infect. Dis. 194(7), 877-885 (2006). (Pubitemid 44454072)
11. Russell KL, Hawksworth AW, Ryan MA et al.: Vaccine-preventable adenoviral respiratory illness in us military recruits, 1999-2004. Vaccine 24(15), 2835-2842 (2006).
12. Esposito DH, Gardner TJ, Schneider E et al.: Outbreak of pneumonia associated with emergent human adenovirus serotype 14-southeast Alaska, 2008. J. Infect. Dis. 202(2), 214-222 (2010).
13. Seto J, Walsh MP, Mahadevan P et al.: Genomic and bioinformatics analyses of hadv-14p, reference strain of a re-emerging respiratory pathogen and analysis of b1/b2. Virus Res. 143(1), 94-105 (2009).
14. Lewis PF, Schmidt MA, Lu X et al.: A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J. Infect. Dis. 199(10), 1427-1434 (2009).
15. Neville JS, Bunning M, Lyons A et al.: Challenges associated with the emergence of adenovirus type 14 at us military training centers. Mil. Med. 173(7), IV-VII (2008).
16. Jones MS 2nd, Harrach B, Ganac RD et al.: New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 81(11), 5978-5984 (2007). (Pubitemid 46847034)
17. Li QG, Wadell G: The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee. Arch. Virol. 101(1-2), 65-77 (1988).
18. Gruber WC, Russell DJ, Tibbetts C: Fiber gene and genomic origin of human adenovirus type 4. Virology 196(2), 603-611 (1993).
19. Purkayastha A, Ditty SE, Su J et al.: Genomic and bioinformatics analysis of hadv-4, a human adenovirus causing acute respiratory disease: Implications for gene therapy and vaccine vector development. J. Virol. 79(4), 2559-2572 (2005). (Pubitemid 40204610)
20. Rosen L: Hemagglutination by adenoviruses. Virology 5(3), 574-577 (1958).
21. Rosen L: Hemagglutination-inhibition antibody responses in human adenovirus infections. Proc. Soc. Exp. Biol. Med. 108, 474-479 (1961).
22. Hierholzer JC, Suggs MT, Hall EC: Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl. Microbiol. 18(5), 824-833 (1969).
23. Wadell G: Hemagglutination with adenovirus serotypes belonging to Rosen's subgroups II and 3. Proc. Soc. Exp. Biol. Med. 132(2), 413-421 (1969).
24. Norrby E, Van Der Veen J, Espmark A: A new serological technique for identification of adenovirus infections. Proc. Soc. Exp. Biol. Med. 134(3), 889-895 (1970).
25. Seiradake E, Henaff D, Wodrich H et al.: The cell adhesion molecule 'Car' and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog. 5(1), E1000277 (2009). ■ Provides a molecular and structural rationale for adenovirus (Ad)-erythrocyte interactions, a basis to improve vector-mediated gene transfer and a mechanism that may explain the biodistribution and pathogenic inconsistencies found between human and animal models.
26. Howe C, Lee LT: Virus-erythrocyte interactions. Adv. Virus Res. 17, 1-50 (1972).
27. Wigand R, Sehn N, Hierholzer JC, De Jong JC, Adrian T: Immunological and biochemical characterization of human adenoviruses from subgenus b. I. Antigenic relationships. Arch. Virol. 84(1-2), 63-78 (1985). (Pubitemid 15116101)
28. Eiz B, Adrian T, Pring-Akerblom P: Recombinant fibre proteins of human adenoviruses Ad9, Ad15 and Ad19: Localization of the haemagglutination properties and the type-specific determinant. Res. Virol. 148(1), 5-10 (1997). (Pubitemid 27062200)
29. Eiz B, Pring-Akerblom P: Molecular characterization of the type-specific g-determinant located on the adenovirus fiber. J. Virol. 71(9), 6576-6581 (1997). (Pubitemid 27355315)
30. Burnett RM: The structure of the adenovirus capsid. II. The packing symmetry of hexon and its implications for viral architecture. J. Mol. Biol. 185(1), 125-143 (1985). (Pubitemid 16250050)
31. Saban SD, Silvestry M, Nemerow GR, Stewart PL: Visualization of α-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J. Virol. 80(24), 12049-12059 (2006). (Pubitemid 44904355)
32. Schoehn G, El Bakkouri M, Fabry CM et al.: Three-dimensional structure of canine adenovirus serotype 2 capsid. J. Virol. 82(7), 3192-3203 (2008). (Pubitemid 351429900)
33. Liu H, Jin L, Koh SB et al.: Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329(5995), 1038-1043 (2010). ■ Along with [34], discusses the long-awaited resolution of the 150-MDa Ad capsid. In this study, it is by cryo-electron microscopy.
34. Reddy VS, Natchiar SK, Stewart PL, Nemerow GR: Crystal structure of human adenovirus at 3.5 a resolution. Science 329(5995), 1071-1075 (2010). ■ As in reference [33], the resolution of the Ad capsid is discussed, but here by x-ray diffraction.
35. Bergelson JM, Cunningham JA, Droguett G et al.: Isolation of a common receptor for coxsackie b viruses and adenoviruses 2 and 5. Science 275(5304), 1320-1323 (1997). (Pubitemid 27114163)
36. Freimuth P, Philipson L, Carson SD: The coxsackievirus and adenovirus receptor. Curr. Top. Microbiol. Immunol. 323, 67-87 (2008).
37. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, Philipson L: Expression of the adenovirus receptor and its interaction with the fiber knob. Exp. Cell. Res. 255(1), 47-55 (2000). (Pubitemid 30115287)
38. Van Raaij MJ, Mitraki A, Lavigne G, Cusack S: A triple b-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 401(6756), 935-938 (1999).
39. Roelvink PW, Lizonova A, Lee JG et al.: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72(10), 7909-7915 (1998). (Pubitemid 28421782)
40. Kirby I, Davison E, Beavil AJ et al.: Identification of contact residues and definition of the car-binding site of adenovirus type 5 fiber protein. J. Virol. 74(6), 2804-2813 (2000). (Pubitemid 30117592)
41. Kirby I, Lord R, Davison E et al.: Adenovirus type 9 fiber knob binds to the coxsackie b virus-adenovirus receptor (CAR) with lower affinity than fiber knobs of other car-binding adenovirus serotypes. J. Virol. 75, 7210-7214 (2001). (Pubitemid 32641612)
42. Davison E, Kirby I, Elliott T, Santis G: The human HLA-a*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J. Virol. 73(5), 4513-4517 (1999). (Pubitemid 29189907)
43. Roelvink PW, Kovesdi I, Wickham TJ: Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J. Virol. 70(11), 7614-7621 (1996). (Pubitemid 26339066)
44. Seiradake E, Lortat-Jacob H, Billet O, Kremer EJ, Cusack S: Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the d1 domain of coxsackie and adenovirus receptor. J. Biol. Chem. 281(44), 33704-33716 (2006). (Pubitemid 46036749)
45. Seiradake E, Cusack S: Crystal structure of enteric adenovirus serotype 41 short fiber head. J. Virol. 79(22), 14088-14094 (2005). (Pubitemid 41552706)
46. Van Raaij MJ, Chouin E, Van Der Zandt H, Bergelson JM, Cusack S: Dimeric structure of the coxsackievirus and adenovirus receptor d1 domain at 1.7 a resolution. Structure 8(11), 1147-1155 (2000). (Pubitemid 32667480)
47. Patzke C, Max KE, Behlke J et al.: The coxsackievirus-adenovirus receptor reveals complex homophilic and heterophilic interactions on neural cells. J. Neurosci. 30(8), 2897-2910 (2010).
48. Marttila M, Persson D, Gustafsson D et al.: Cd46 is a cellular receptor for all species b adenoviruses except types 3 and 7. J. Virol. 79(22), 14429-14436 (2005). (Pubitemid 41552740)
49. Gaggar A, Shayakhmetov DM, Lieber A: Cd46 is a cellular receptor for group b adenoviruses. Nat. Med. 9(11), 1408-1412 (2003). (Pubitemid 37466191)
50. Iacobelli-Martinez M, Nepomuceno RR, Connolly J, Nemerow GR: Cd46-utilizing adenoviruses inhibit C/EBPβ-dependent expression of proinflammatory cytokines. J. Virol. 79(17), 11259-11268 (2005). (Pubitemid 41170668)
51. Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A: Members of adenovirus species b utilize cd80 and cd86 as cellular attachment receptors. Virus Res. 122(1-2), 144-153 (2006). (Pubitemid 44740333)
52. Arnberg N, Edlund K, Kidd AH, Wadell G: Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74(1), 42-48 (2000). (Pubitemid 30002881)
53. Arnberg N, Kidd AH, Edlund K, Olfat F, Wadell G: Initial interactions of subgenus D adenoviruses with a549 cellular receptors: Sialic acid versus α(v) integrins. J. Virol. 74(16), 7691-7693 (2000). (Pubitemid 30613120)
54. Arnberg N, Pring-Akerblom P, Wadell G: Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J. Virol. 76(17), 8834-8841 (2002). (Pubitemid 34864078)
55. Johansson C, Jonsson M, Marttila M et al.: Adenoviruses use lactoferrin as a bridge for car-independent binding to and infection of epithelial cells. J. Virol. 81(2), 954-963 (2007). (Pubitemid 46067920)
56. Dugan AS, Eash S, Atwood WJ: Update on BK virus entry and intracellular trafficking. Transpl. Infect. Dis. 8(2), 62-67 (2006). (Pubitemid 43829482)
57. Isa P, Arias Cf, Lopez S: Role of sialic acids in rotavirus infection. Glycoconj. J. 23(1-2), 27-37 (2006).
58. Olofsson S, Bergstrom T: Glycoconjugate glycans as viral receptors. Ann. Med. 37(3), 154-172 (2005). (Pubitemid 40780433)
59. Schwegmann-Wessels C, Herrler G: Sialic acids as receptor determinants for coronaviruses. Glycoconj. J. 23(1-2), 51-58 (2006).
60. Forrest JC, Dermody TS: Reovirus receptors and pathogenesis. J. Virol. 77(17), 9109-9115 (2003). (Pubitemid 37011008)
61. Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, Lieber A: Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog. 4(10), E1000189 (2008).
62. Tuve S, Wang H, Ware C et al.: A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J. Virol. 80(24), 12109-12120 (2006). (Pubitemid 44904362)
63. Wang H, Li ZY, Liu Y et al.: Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17(1), 96-104 (2011).
64. Waddington SN, Mcvey JH, Bhella D et al.: Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132(3), 397-409 (2008). ■ The role of hexon in Ad uptake and the role of coagulation factors in Ad tropism. (Pubitemid 351200513)
65. Alba R, Bradshaw AC, Parker AL et al.: Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: Effect of mutagenesis on FX interactions and gene transfer. Blood 114(5), 965-971 (2009).
66. Parker AL, Waddington SN, Buckley SM et al.: Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer. J. Virol. 83(1), 479-483 (2009).
67. Bradshaw AC, Parker AL, Duffy MR et al.: Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor x. PLoS Pathog. 6(10), PII: E1001142 (2010).
68. Lyon M, Deakin JA, Gallagher JT: Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 269(15), 11208-11215 (1994).
69. Burmeister WP, Guilligay D, Cusack S, Wadell G, Arnberg N: Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites. J. Virol. 78(14), 7727-7736 (2004). (Pubitemid 38915919)
70. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ: Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110(6), 789-799 (2002). (Pubitemid 35283966)
71. Soudais C, Boutin S, Hong SS et al.: Canine adenovirus type 2 attachment and internalization: Coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J. Virol. 74(22), 10639-10649 (2000).
72. Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ: Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. FASEB J. 15(12), 2283-2285 (2001).
73. Salinas S, Bilsland LG, Henaff D et al.: Car-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog. 5(5), E1000442 (2009). ■ Unexpected vesicular trafficking of an Ad in neurons highlighting the divergence of trafficking between cell types.
74. Kremer EJ: CAR chasing: Canine adenovirus vectors-all bite and no bark? J. Gene Med. 6(Suppl. 1), S139-S151 (2004). (Pubitemid 40228023)
75. Li X, Bangari DS, Sharma A, Mittal SK: Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry. Virology 392(2), 162-168 (2009).
76. Bangari DS, Mittal SK: Porcine adenovirus serotype 3 internalization is independent of car and αvβ3 or αvβ5 integrin. Virology 332(1), 157-166 (2005). (Pubitemid 40127237)
77. Hess M, Cuzange A, Ruigrok RW, Chroboczek J, Jacrot B: The avian adenovirus penton: Two fibres and one base. J. Mol. Biol. 252(4), 379-385 (1995).
78. Tan PK, Michou AI, Bergelson JM, Cotten M: Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins. J. Gen. Virol. 82(Pt 6), 1465-1472 (2001). (Pubitemid 32519778)
79. Guardado-Calvo P, Llamas-Saiz Al, Fox GC, Langlois P, Van Raaij MJ: Structure of the c-terminal head domain of the fowl adenovirus type 1 long fiber. J. Gen. Virol. 88(Pt 9), 2407-2416 (2007). (Pubitemid 47323885)
80. El Bakkouri M, Seiradake E, Cusack S, Ruigrok RW, Schoehn G: Structure of the c-terminal head domain of the fowl adenovirus type 1 short fibre. Virology 378(1), 169-176 (2008).
81. Asher DR, Cerny AM, Finberg RW: The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus b infection. Proc. Natl Acad. Sci. USA 102(36), 12897-12902 (2005). (Pubitemid 41279461)
82. Carlisle RC, Di Y, Cerny AM et al.: Human erythrocytes bind and inactivate type 5 adenovirus by presenting coxsackie virus-adenovirus receptor and complement receptor 1. Blood 113(9), 1909-1918 (2009). ■ This study confirmed the role of coxsackievirus B and Ad receptor on erythrocytes and the possible role of CR1 in human Ad-5 in vivo biodistribution.
83. Leopold PL, Crystal RG: Intracellular trafficking of adenovirus: Many means to many ends. Adv. Drug Deliv. Rev. 59(8), 810-821 (2007). (Pubitemid 47320816)
84. Meier O, Greber UF: Adenovirus endocytosis. J. Gene Med. 6(Suppl. 1), S152-S163 (2004).
85. Meier O, Gastaldelli M, Boucke K, Hemmi S, Greber UF: Early steps of clathrin-mediated endocytosis involved in phagosomal escape of fcg receptor-targeted adenovirus. J. Virol. 79(4), 2604-2613 (2005). (Pubitemid 40204614)
86. Meier O, Boucke K, Hammer SV et al.: Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell. Biol. 158(6), 1119-1131 (2002).
87. Colin M, Mailly L, Rogee S, D'halluin JC: Efficient species c hadv infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route. Mol. Ther. 11(2), 224-236 (2005).
88. Doherty GJ, Mcmahon HT: Mechanisms of endocytosis. Ann. Rev. Biochem. 78, 857-902 (2009).
89. Boucrot E, Saffarian S, Zhang R, Kirchhausen T: Roles of ap-2 in clathrin-mediated endocytosis. PLoS ONE 5(5), E10597 (2010).
90. Nakano MY, Boucke K, Suomalainen M, Stidwill RP, Greber UF: The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 74(15), 7085-7095 (2000). (Pubitemid 30470693)
91. Mathias P, Galleno M, Nemerow GR: Interactions of soluble recombinant integrin αv β5 with human adenoviruses. J. Virol. 72(11), 8669-8675 (1998). (Pubitemid 28471806)
92. Chiu CY, Mathias P, Nemerow GR, Stewart PL: Structure of adenovirus complexed with its internalization receptor, αvβ5 integrin. J. Virol. 73(8), 6759-6768 (1999). (Pubitemid 29327859)
93. Nemerow GR, Cheresh DA, Wickham TJ: Adenovirus entry into host cells: A role for α(v) integrins. Trends Cell Biol. 4(2), 52-55 (1994).
94. Mathias P, Wickham T, Moore M, Nemerow G: Multiple adenovirus serotypes use α v integrins for infection. J. Virol. 68(10), 6811-6814 (1994). (Pubitemid 24294939)
95. Venail F, Wang J, Ruel J et al.: Coxsackie adenovirus receptor and α nu β3/α nu β5 integrins in adenovirus gene transfer of rat cochlea. Gene Ther. 14(1), 30-37 (2007). (Pubitemid 44942863)
96. Majhen D, Nemet J, Richardson J et al.: Differential role of α(v)β(3) and α(v)β(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses. Virus Res. 139(1), 64-73 (2009).
97. Chillon M, Kremer EJ: Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif. Hum. Gene Ther. 12(14), 1815-1823 (2001). (Pubitemid 32911646)
98. Kalin S, Amstutz B, Gastaldelli M et al.: Macropinocytotic uptake and infection of human epithelial cells with species b2 adenovirus type 35. J. Virol. 84(10), 5336-5350 (2010).
99. Crimeen-Irwin B, Ellis S, Christiansen D et al.: Ligand binding determines whether cd46 is internalized by clathrin-coated pits or macropinocytosis. J. Biol. Chem. 278(47), 46927-46937 (2003). (Pubitemid 37452275)
100. Greber UF: Signalling in viral entry. Cell Mol. Life Sci. 59(4), 608-626 (2002). (Pubitemid 34457539)
101. Farmer C, Morton PE, Snippe M, Santis G, Parsons M: Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK. Exp. Cell. Res. 315(15), 2637-2647 (2009).
102. Verdino P, Witherden DA, Havran WL, Wilson IA: The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science 329(5996), 1210-1214 (2010).
103. Imelli N, Meier O, Boucke K, Hemmi S, Greber UF: Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. J. Virol. 78(6), 3089-3098 (2004). (Pubitemid 38314367)
104. Luzio JP, Mullock BM, Pryor PR, Lindsay MR, James DE, Piper RC: Relationship between endosomes and lysosomes. Biochem. Soc. Trans. 29(Pt 4), 476-480 (2001). (Pubitemid 32783641)
105. Gastaldelli M, Imelli N, Boucke K, Amstutz B, Meier O, Greber UF: Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 9(12), 2265-2278 (2008).
106. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR: Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79(4), 1992-2000 (2005). ■ A model of Ad endosomolysis is proposed based on protein VI-mediated capsid disassembly and membrane penetration. (Pubitemid 40204556)
107. Wodrich H, Henaff D, Jammart B et al.: A capsid-encoded PPXY-motif facilitates adenovirus entry. PLoS Pathog. 6(3), E1000808 (2010). ■ This study provides the first evidence that virus-encoded PPxY motifs are required during Ad entry, which may be of significance for several other pathogens.
108. Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR, Stewart PL: Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 6(6), E1000959 (2010).
109. Smith JG, Nemerow GR: Mechanism of adenovirus neutralization by human a-defensins. Cell Host Microbe 3(1), 11-19 (2008).
110. Maier O, Galan DL, Wodrich H, Wiethoff CM: An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology 402(1), 11-19 (2010).
111. Bailey CJ, Crystal RG, Leopold PL: Association of adenovirus with the microtubule organizing center. J. Virol. 77(24), 13275-13287 (2003). (Pubitemid 37494323)
112. Leopold P, Ferris B, Grinsberg I, Worgall S, Hackett N, Crystal R: Fluorescent virions: Dynamics tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9, 367-378 (1998). (Pubitemid 28085024)
113. Leopold PL, Ferris B, Grinberg I, Worgall S, Hackett NR, Crystal RG: Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9(3), 367-378 (1998). (Pubitemid 28085024)
114. Leopold PL, Kreitzer G, Miyazawa N et al.: Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum. Gene Ther. 11(1), 151-165 (2000). (Pubitemid 30044048)
115. Leopold PL, Wendland RL, Vincent T, Crystal RG: Neutralized adenovirus-immune complexes can mediate effective gene transfer via an FC receptor-dependent infection pathway. J. Virol. 80(20), 10237-10247 (2006). (Pubitemid 44522617)
116. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF: Import of adenovirus DNA involves the nuclear pore complex receptor can/nup214 and histone h1. Nat. Cell. Biol. 3(12), 1092-1100 (2001). (Pubitemid 33130460)
117. Smith JG, Cassany A, Gerace L, Ralston R, Nemerow GR: Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J. Virol. 82(13), 6492-6500 (2008). (Pubitemid 351875126)
118. Bremner KH, Scherer J, Yi J, Vershinin M, Gross SP, Vallee RB: Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6(6), 523-535 (2009).
119. Kelkar SA, Pfister KK, Crystal RG, Leopold PL: Cytoplasmic dynein mediates adenovirus binding to microtubules. J. Virol. 78(18), 10122-10132 (2004). (Pubitemid 39187130)
120. Wodrich H, Guan T, Cingolani G, Von Seggern D, Nemerow G, Gerace L: Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J. 22(23), 6245-6255 (2003). (Pubitemid 37522582)
121. Gazzola M, Burckhardt CJ, Bayati B, Engelke M, Greber UF, Koumoutsakos P: A stochastic model for microtubule motors describes the in vivo cytoplasmic transport of human adenovirus. PLoS Comput. Biol. 5(12), E1000623 (2009).
122. Glotzer JB, Michou AI, Baker A, Saltik M, Cotten M: Microtubule- independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes. J. Virol. 75(5), 2421-2434 (2001). (Pubitemid 32147580)
123. Yea C, Dembowy J, Pacione L, Brown M: Microtubule-mediated and microtubule-independent transport of adenovirus type 5 in hek293 cells. J. Virol. 81(13), 6899-6908 (2007). (Pubitemid 46986626)
124. Strunze S, Trotman LC, Boucke K, Greber UF: Nuclear targeting of adenovirus type 2 requires crm1-mediated nuclear export. Mol. Biol. Cell. 16(6), 2999-3009 (2005). (Pubitemid 40741242)
125. Hnasko TS, Sotak BN, Palmiter RD: Morphine reward in dopamine-deficient mice. Nature 438(7069), 854-857 (2005). (Pubitemid 41753067)
126. Hnasko TS, Perez FA, Scouras AD et al.: Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc. Natl Acad. Sci. USA 103(23), 8858-8863 (2006). (Pubitemid 43878108)
127. Yang Y, Ertl HC, Wilson JM: MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with e1-deleted recombinant adenoviruses. Immunity 1(5), 433-442 (1994).
128. Di Paolo NC, Miao EA, Iwakura Y et al.: Virus binding to a plasma membrane receptor triggers interleukin-1 α-mediated proinflammatory macrophage response in vivo. Immunity 31(1), 110-121 (2009).
129. Perreau M, Pantaleo G, Kremer EJ: Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J. Exp. Med. 205(12), 2717-2725 (2008).
130. Ragot T, Vincent N, Chafey P et al.: Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650 (1993). (Pubitemid 23062399)
131. Fabry CM, Rosa-Calatrava M, Conway JF et al.: A quasi-atomic model of human adenovirus type 5 capsid. EMBO J. 24, 1645-1654 (2005). (Pubitemid 40704975)
132. Brosch L, Tchandja J, Marconi V et al.: Adenovirus serotype 14 pneumonia at a basic military training site in the united states, spring 2007: A case series. Mil. Med. 174(12), 1295-1299 (2009).
133. Gray GC, Chorazy ML: Human adenovirus 14a: A new epidemic threat. J. Infect. Dis. 199(10), 1413-1415 (2009).
134. Garnett CT, Talekar G, Mahr JA et al.: Latent species c adenoviruses in human tonsil tissues. J. Virol. 83(6), 2417-2428 (2009).
135. O'Shea CC, Soria C, Bagus B, Mccormick F: Heat shock phenocopies e1b-55k late functions and selectively sensitizes refractory tumor cells to onyx-015 oncolytic viral therapy. Cancer Cell 8(1), 61-74 (2005). (Pubitemid 40991815)
136. Kaufman DR, Bivas-Benita M, Simmons NL, Miller D, Barouch DH: Route of adenovirus-based hiv-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J. Virol. 84(12), 5986-5996 (2010).
137. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK: Epigenetic reprogramming by adenovirus e1a. Science 321(5892), 1086-1088 (2008).
138. Horwitz GA, Zhang K, Mcbrian MA, Grunstein M, Kurdistani SK, Berk AJ: Adenovirus small e1a alters global patterns of histone modification. Science 321(5892), 1084-1085 (2008).
139. Nilsson EC, Storm RJ, Bauer J et al.: The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17(1), 105-109 (2011).
140. Arnberg N: Adenovirus receptors: Implications for tropism, treatment and targeting. Rev. Med. Virol. 19(3), 165-178 (2009).
141. Coyne CB, Bergelson JM: CAR: A virus receptor within the tight junction. Adv. Drug Deliv. Rev. 57(6), 869-882 (2005). (Pubitemid 40488108)
142. Ashbourne Excoffon KJ, Moninger T, Zabner J: The coxsackie b virus and adenovirus receptor resides in a distinct membrane microdomain. J. Virol. 77(4), 2559-2567 (2003). ■ Residence in a lipid-rich domain provides a mechanism that allows coxsackievirus B and Ad receptor to interact with other cell adhesion proteins and yet function as an Ad receptor. (Pubitemid 36222780)
143. Shieh JT, Bergelson JM: Interaction with decay-accelerating factor facilitates coxsackievirus b infection of polarized epithelial cells. J. Virol. 76(18), 9474-9480 (2002). (Pubitemid 34919904)
144. Coyne CB, Bergelson JM: Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124(1), 119-131 (2006). (Pubitemid 43069314)
145. Diaz F, Gravotta D, Deora A et al.: Clathrin adaptor AP1B controls adenovirus infectivity of epithelial cells. Proc. Natl Acad. Sci. USA 106(27), 11143-11148 (2009).
146. Excoffon KJ, Gansemer ND, Mobily ME, Karp PH, Parekh KR, Zabner J: Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia. PLoS ONE 5(3), E9909 (2010).
147. Shaw CA, Holland PC, Sinnreich M et al.: Isoform-specific expression of the coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. BMC Cell Biol. 5(1), 42 (2004).
148. Huang J, Tamisier R, Ji E, Tong J, Weiss WJ: Chronic intermittent hypoxia modulates nnos mRNA and protein expression in the rat hypothalamus. Respir. Physiol. Neurobiol. 158(1), 30-38 (2007). (Pubitemid 46935581)
149. Fok PT, Huang KC, Holland PC, Nalbantoglu J: The coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration. J. Biol. Chem. 282(10), 7512-7521 (2007). (Pubitemid 47093696)
150. Henaff D, Kremer EJ: [adenovirus hexon mediates liver gene transfer]. Med. Sci. (Paris) 24(8-9), 673-675 (2008).
151. Persson BD, Reiter DM, Marttila M et al.: Adenovirus type 11 binding alters the conformation of its receptor cd46. Nat. Struct. Mol. Biol. 14(2), 164-166 (2007). ■ Evidence that a viral protein can remodel its cellular receptor.
152. Persson BD, Muller S, Reiter DM et al.: An arginine switch in the species b adenovirus knob determines high-affinity engagement of cellular receptor cd46. J. Virol. 83(2), 673-686 (2009).
153. Henaff D, Salinas S: An endocytic carriage tale: Adenoviruses internalization and trafficking in neurons. Virulence 1(3), 188-191(2010).